| Conformation-specific spectroscopy and photodissociation of cold, protonated tyrosine and phenylalanine JA Stearns, S Mercier, C Seaiby, M Guidi, OV Boyarkin, TR Rizzo Journal of the American Chemical Society 129 (38), 11814-11820, 2007 | 224 | 2007 |
| Conformation-specific infrared and ultraviolet spectroscopy of tyrosine-based protonated dipeptides JA Stearns, M Guidi, OV Boyarkin, TR Rizzo The Journal of chemical physics 127 (15), 2007 | 95 | 2007 |
| The steps to therapeutic drug monitoring: a structured approach illustrated with imatinib T Buclin, Y Thoma, N Widmer, P André, M Guidi, C Csajka, LA Decosterd Frontiers in pharmacology 11, 177, 2020 | 87 | 2020 |
| Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates A Fuchs, M Guidi, E Giannoni, D Werner, T Buclin, N Widmer, C Csajka British journal of clinical pharmacology 78 (5), 1090-1101, 2014 | 66 | 2014 |
| Effect of Single Nucleotide Polymorphisms in Cytochrome P450 Isoenzyme and N-Acetyltransferase 2 Genes on the Metabolism of Artemisinin-Based Combination … EM Staehli Hodel, C Csajka, F Ariey, M Guidi, AM Kabanywanyi, S Duong, ... Antimicrobial agents and chemotherapy 57 (2), 950-958, 2013 | 65 | 2013 |
| The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material P Wahl, M Guidi, E Benninger, K Rönn, E Gautier, T Buclin, JL Magnin, ... The bone & joint journal 99 (11), 1537-1544, 2017 | 61 | 2017 |
| Genetics-based population pharmacokinetics and pharmacodynamics of risperidone in a psychiatric cohort F Vandenberghe, M Guidi, E Choong, A von Gunten, P Conus, C Csajka, ... Clinical pharmacokinetics 54, 1259-1272, 2015 | 61 | 2015 |
| Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV P Courlet, F Livio, M Guidi, M Cavassini, M Battegay, M Stoeckle, T Buclin, ... Open Forum Infectious Diseases 6 (12), ofz531, 2019 | 55 | 2019 |
| Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV P Courlet, F Livio, M Guidi, M Cavassini, M Battegay, M Stoeckle, T Buclin, ... Open Forum Infectious Diseases 6 (12), ofz531, 2019 | 55 | 2019 |
| Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance M Noetzli, M Guidi, K Ebbing, S Eyer, L Wilhelm, A Michon, V Thomazic, ... British journal of clinical pharmacology 78 (1), 135-144, 2014 | 55 | 2014 |
| Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania D Mosha, M Guidi, F Mwingira, S Abdulla, T Mercier, LA Decosterd, ... Antimicrobial agents and chemotherapy 58 (8), 4583-4592, 2014 | 53 | 2014 |
| Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life … R Burger, M Guidi, V Calpini, F Lamoth, L Decosterd, C Robatel, T Buclin, ... Journal of Antimicrobial Chemotherapy 73 (12), 3413-3422, 2018 | 50 | 2018 |
| Spectroscopy of protonated peptides assisted by infrared multiple photon excitation M Guidi, UJ Lorenz, G Papadopoulos, OV Boyarkin, TR Rizzo The Journal of Physical Chemistry A 113 (5), 797-799, 2009 | 49 | 2009 |
| Population pharmacokinetics and pharmacogenetics analysis of rilpivirine in HIV-1-infected individuals M Aouri, C Barcelo, M Guidi, M Rotger, M Cavassini, C Hizrel, T Buclin, ... Antimicrobial agents and chemotherapy 61 (1), 10.1128/aac. 00899-16, 2017 | 46 | 2017 |
| Population pharmacokinetic study of memantine: effects of clinical and genetic factors M Noetzli, M Guidi, K Ebbing, S Eyer, L Wilhelm, A Michon, V Thomazic, ... Clinical pharmacokinetics 52, 211-223, 2013 | 45 | 2013 |
| Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients EM Staehli Hodel, M Guidi, B Zanolari, T Mercier, S Duong, ... Malaria journal 12, 1-17, 2013 | 44 | 2013 |
| Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literature E Petit-Jean, T Buclin, M Guidi, E Quoix, B Gourieux, LA Decosterd, ... Therapeutic drug monitoring 37 (1), 2-21, 2015 | 43 | 2015 |
| Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours A Haouala, N Widmer, M Guidi, M Montemurro, S Leyvraz, T Buclin, ... British journal of clinical pharmacology 75 (4), 1007-1018, 2013 | 43 | 2013 |
| Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations M Noetzli, M Guidi, K Ebbing, S Eyer, S Zumbach, P Giannakopoulos, ... Therapeutic drug monitoring 35 (2), 270-275, 2013 | 39 | 2013 |
| Population pharmacokinetics of dolutegravir: influence of drug–drug interactions in a real-life setting C Barcelo, M Aouri, P Courlet, M Guidi, DL Braun, HF Günthard, RJ Piso, ... Journal of Antimicrobial Chemotherapy 74 (9), 2690-2697, 2019 | 38 | 2019 |
